p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in MiceSummary

Background & Aims: Progression of chronic liver disease (CLD) to liver cirrhosis and liver cancer is a major global cause of morbidity and mortality. Treatment options capable of inhibiting progression of liver fibrosis when etiological treatment of CLD is not available or fails have yet to...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Florian P. Reiter, Liangtao Ye, Andrea Ofner, Tobias S. Schiergens, Andreas Ziesch, Lydia Brandl, Najib Ben Khaled, Simon Hohenester, Ralf Wimmer, Renate Artmann, Yulong He, Serene M.L. Lee, Doris Mayr, Changhua Zhang, Alexander L. Gerbes, Julia Mayerle, Gerald Denk, Enrico N. De Toni
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Fibrosis Cirrhosis Chronic Liver Disease Transforming Growth Factor-β Platelet-Derived Growth Factor BB Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/d5c1e3f3e4744b00bcc68fbf2299c769
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in MiceSummary

Ejemplares similares